PAI II536 integrates site-specifically into the E coli K-12 chro

PAI II536 integrates site-specifically into the E. coli K-12 chromosome at the tRNA gene leuX Upon conjugation, the transferred circularised form of the PAI II536 derivative can integrate into the recipient’s chromosome. Additionally, the recipient strain SY327λpir also enables episomal replication of the transferred CI. Analysis by PCR of the transconjugants carrying the complete PAI II536 derivative allowed to distinguish between chromosomally inserted and episomal LEE011 in vitro circular forms of the PAI II536 construct. Episomal CIs could not be detected in the clones with the chromosomally inserted PAI II536 derivative. As exemplarily shown for clones 23, 46, and 54, the orientation of the

site-specifically integrated PAI II536 within the chromosome was determined by using combinations of the four primer pairs indicated in Figure 1. In these three clones as well as in donor strain 536, PCR screening products could only be obtained using primer pairs 2 and 5, which amplify the ends of PAI II536 with the adjacent core genome context. Primer pair 1 amplifies the empty leuX locus in the core genome context and gave only a PCR product in the recipient strain SY327. Accordingly, PAI II536 has been inserted into the leuX gene of the E. coli SY327 chromosome

in the identical orientation as in the donor chromosome (Figure 1). Genomic restriction patterns of representative transconjugants, carrying either the chromosomally inserted PAI II536 derivative or its episomal CI, were

compared to each click here other and to those of the donor and recipient strain by PFGE in order to assess their genomic homogeneity (Figure 2). Generally, the restriction patterns of the transconjugants were very similar to that of recipient strain SY327λpir. The PFGE patterns of the selected transconjugants which carried the transferred PAI II536 in their chromosome exhibited only minor differences among each other. Similarly, the restriction patterns of the clones containing the stable episomal CI of PAI Masitinib (AB1010) II536 were identical. Both groups of transconjugants could be clearly distinguished upon the presence of a ~400-kb and a ~530-kb restriction fragment in those recipient clones with a stable cytoplasmic PAI II536 CI which were absent from recipients in which chromosomal integration of the island occurred. Instead, a restriction fragment of about 700 kb was visible in the latter clones (Figure 2). This larger restriction fragment may comprise the 530-kb restriction fragment after chromosomal insertion of the transferred PAI II536 (107-kb) construct. These data demonstrate that PAI II536 can be mobilized upon excision from the chromosome by helper plasmids into suitable recipient strains. Upon transfer, the majority of CIs integrates site-specifically into the recipient’s chromosome at the leuX locus or remains as an episomal CI. Figure 2 Analysis of the genomic restriction pattern of different recipient clones upon transfer of PAI II 536 by PFGE.

Comments are closed.